Follow
Heba A. Ewida
Heba A. Ewida
Biochemistry department, Faculty of Pharmacy, Future University in Egypt
Verified email at fue.edu.eg
Title
Cited by
Cited by
Year
Synthesis, biological evaluation and molecular modeling study of new (1, 2, 4-triazole or 1, 3, 4-thiadiazole)-methylthio-derivatives of quinazolin-4 (3H)-one as DHFR inhibitors
YI El-Gazzar, HH Georgey, SM El-Messery, HA Ewida, GS Hassan, ...
Bioorganic Chemistry 72, 282-292, 2017
502017
Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer
MI Shabayek, OM Sayed, HA Attaia, HA Awida, H Abozeed
Pathology & Oncology Research 20, 859-866, 2014
352014
Thiazolo [4, 5-d] pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study
MA Ewida, DA Abou El Ella, DS Lasheen, HA Ewida, YI El-Gazzar, ...
Bioorganic chemistry 74, 228-237, 2017
262017
Imidazo [2′, 1′: 2, 3] thiazolo [4, 5-d] pyridazinone as a new scaffold of DHFR inhibitors: Synthesis, biological evaluation and molecular modeling study
MA Ewida, DA Abou El Ella, DS Lasheen, HA Ewida, YI El-Gazzar, ...
Bioorganic Chemistry 80, 11-23, 2018
252018
Design, synthesis, and biological evaluation of novel amide and hydrazide based thioether analogs targeting Histone deacteylase (HDAC) enzymes
AB Farag, HA Ewida, MS Ahmed
European journal of medicinal chemistry 148, 73-85, 2018
202018
Evaluation and screening of mRNA S100A genes as serological biomarkers in different stages of bladder cancer in Egypt
MF Ismail, NA El Boghdady, MI Shabayek, HA Awida, H Abozeed
Tumor Biology 37, 4621-4631, 2016
192016
Synthesis, antitumor testing and molecular modeling study of some new 6-substituted amido, azo or thioureido-quinazolin-4 (3H)-ones
MA Sabry, HA Ewida, GS Hassan, MA Ghaly, HI El-Subbagh
Bioorganic Chemistry 88, 102923, 2019
172019
MicroRNAs 342 and 450 together with NOX‐4 activity and their association with coronary artery disease in diabetes
M Seleem, M Shabayek, HA Ewida
Diabetes/Metabolism Research and Reviews 35 (5), e3130, 2019
122019
Circulating lncRNAs HIF1A-AS2 and LINLK-A: Role and relation to hypoxia-inducible factor-1α in cerebral stroke patients
HA Ewida, RK Zayed, HA Darwish, AA Shaheen
Molecular Neurobiology 58 (9), 4564-4574, 2021
82021
Promising role of topical caffeine mesoporous gel in collagen resynthesis and UV protection through proline assessment
M Seleem, YS Abulfadl, NE Hoffy, NM Lotfy, HA Ewida
Future Journal of Pharmaceutical Sciences 8 (1), 27, 2022
72022
3-Methyl-imidazo [2, 1-b] thiazole derivatives as a new class of antifolates: Synthesis, in vitro/in vivo bio-evaluation and molecular modeling simulations
MA Ewida, HA Ewida, MS Ahmed, HA Allam, RI ElBagary, RF George, ...
Bioorganic Chemistry 115, 105205, 2021
72021
Nanomolar potency of imidazo[2,1‐b]thiazole analogs as indoleamine 2,3‐dioxygenase inhibitors
MA Ewida, HA Ewida, MS Ahmed, HA Allam, RI ElBagary, RF George, ...
Archiv der Pharmazie 354 (11), 2100202, 2021
42021
Successful stories of drug repurposing for cancer therapy in hepatocellular carcinoma
YM Attia, H Ewida, MS Ahmed
Drug Repurposing in Cancer Therapy, 213-229, 2020
42020
Inhibition of pyruvate dehydrogenase in the heart as an initiating event in the development of diabetic cardiomyopathy
A Elnwasany, HA Ewida, PA Szweda, LI Szweda
Antioxidants 12 (3), 756, 2023
32023
Evaluation of miRNAs 9 and 342 expressions in sera as diagnostic and prognostic biomarkers for breast cancer
HA Ewida, M Shabayek, M Seleem
Breast Disease 40 (4), 241-250, 2021
12021
Antiproliferative and apoptotic activities of tomato bioactive metabolite on MDA-MB-435 cell line: in silico molecular modeling and molecular dynamics investigation
YA Elkhawas, MA Ewida, HA Ewida, M Gonaid, N Khalil
Future Journal of Pharmaceutical Sciences 9 (1), 87, 2023
2023
Altered Lnc-EGFR, SNHG1, and LincRNA-Cox2 Profiles in Patients with Relapsing-Remitting Multiple Sclerosis: Impact on Disease Activity and Progression
MS Attia, HA Ewida, MA Abdel Hafez, SA El-Maraghy, MM El-Sawalhi
Diagnostics 13 (8), 1448, 2023
2023
Successful Stories of Drug Repurposing for Cancer Therapy in Hepatocellular Carcinoma, To and Cho_Drug Repurposing in Cancer Therapy
YM Attia, H Ewida, M Ahmed
2020
Dihydrofolate reductase (DHFR) inhibition and molecular modeling study of some 6-bromo- or 6,8-dibromo-quinazolin-4(3H)-ones
HIES Abdelfattah A. Abdelkhalek, Heba A. Ewida, Shahenda M. El-Messery ...
AMERICAN JOURNAL OF PHYSIOLOGY, BIOCHEMISTRY AND PHARMACOLOGY 7 (1), 1-10, 2018
2018
Antioxidants Reveal Protection against the Biochemical Changes in Liver, Kidney and Blood Profiles after Clindamycin/Ibuprofen Administration in Dental Patients
GK Helal, MI Shabayek, HA El-Ramly, HA Awida
International Journal of Pharmacological and Pharmaceutical Sciences 8 (9 …, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–20